{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T02:05:13Z","timestamp":1648951513306},"reference-count":25,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.3892\/mco.2016.947","type":"journal-article","created":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T11:20:07Z","timestamp":1467372007000},"page":"227-230","source":"Crossref","is-referenced-by-count":0,"title":["Myelodysplastic syndrome without ring sideroblasts and with Janus kinase 2 gene mutation: An unusual case report"],"prefix":"10.3892","volume":"5","author":[{"given":"Maria Helena","family":"Ornellas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monique","family":"De Fran\u00e7a Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristiana","family":"Solza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stella Beatriz Sampaio","family":"De Lucena Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liliane","family":"Silva De Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jackline","family":"De Paula Ayres-Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ta\u00eds Leite","family":"Seixas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elenice Ferreira","family":"Bastos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Liehr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilda","family":"Alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2016,7,1]]},"reference":[{"key":"key20180107150104_b1-mco-0-0-947","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/ajh.24102","article-title":"Myelodysplastic syndromes: 2015 Update on diagnosis, risk-stratification and management","volume":"90","author":"Garcia-Manero","year":"2015","journal-title":"Am J Hematol"},{"key":"key20180107150104_b2-mco-0-0-947","doi-asserted-by":"crossref","first-page":"4841","DOI":"10.1182\/blood-2007-08-078139","article-title":"Myelodysplastic syndromes","volume":"111","author":"Nimer","year":"2008","journal-title":"Blood"},{"key":"key20180107150104_b3-mco-0-0-947","first-page":"87","article-title":"Myelodysplastic syndromes\/neoplasms, overview","author":"Brunning","year":"2008","journal-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues"},{"key":"key20180107150104_b4-mco-0-0-947","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1309\/AJCPJ71PTVIKGEVT","article-title":"Myelodysplastic\/myeloproliferative neoplasms","volume":"132","author":"Foucar","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"key20180107150104_b5-mco-0-0-947","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.hoc.2010.02.011","article-title":"The epidemiology of myelodysplastic syndromes","volume":"24","author":"Sekeres","year":"2010","journal-title":"Hematol Oncol Clin North Am"},{"key":"key20180107150104_b6-mco-0-0-947","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.leukres.2004.07.014","article-title":"A retrospective analysis of myelodysplastic syndromes with thrombocytosis: Reclassification of the cases by WHO proposals","volume":"29","author":"Cabello","year":"2005","journal-title":"Leuk Res"},{"key":"key20180107150104_b7-mco-0-0-947","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","article-title":"International prognostic scoring system for evaluating prognosis in myelodysplastic syndromes","volume":"89","author":"Greenberg","year":"1997","journal-title":"Blood"},{"key":"key20180107150104_b8-mco-0-0-947","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2012-03-420489","article-title":"Revised international prognosis scoring system for myelodysplastic syndromes","volume":"120","author":"Greenberg","year":"2012","journal-title":"Blood"},{"key":"key20180107150104_b9-mco-0-0-947","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.1182\/blood-2007-03-082404","article-title":"New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: Evidence from a core dataset of 2124 patients","volume":"110","author":"Haase","year":"2007","journal-title":"Blood"},{"key":"key20180107150104_b10-mco-0-0-947","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00277-008-0450-7","article-title":"Erythropoiesis-stimulating agents in the treatment of anemia in myelodysplastic syndromes: A meta-analysis","volume":"87","author":"Moyo","year":"2008","journal-title":"Ann Hematol"},{"key":"key20180107150104_b11-mco-0-0-947","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJMoa061292","article-title":"Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion","volume":"355","author":"List","year":"2006","journal-title":"N Engl J Med"},{"key":"key20180107150104_b12-mco-0-0-947","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1182\/blood-2011-01-330126","article-title":"A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with low-\/intermediate-1 risk myelodysplastic syndromes with del5q","volume":"118","author":"Fenaux","year":"2011","journal-title":"Blood"},{"key":"key20180107150104_b13-mco-0-0-947","doi-asserted-by":"crossref","first-page":"4280","DOI":"10.1182\/blood-2013-02-453068","article-title":"How we treat lower-risk myelodysplastc syndromes","volume":"121","author":"Fenaux","year":"2013","journal-title":"Blood"},{"issue":"Suppl 3","key":"key20180107150104_b14-mco-0-0-947","doi-asserted-by":"crossref","first-page":"iii57","DOI":"10.1093\/annonc\/mdu180","article-title":"Guidelines Working Group: Myelodysplastic syndromes: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"25","author":"Fenaux","year":"2014","journal-title":"Ann Oncol"},{"key":"key20180107150104_b15-mco-0-0-947","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/ajh.23642","article-title":"Myelodysplastic syndromes: 2014 update on diagnosis, risk-stratification, and management","volume":"89","author":"Garcia-Manero","year":"2014","journal-title":"Am J Hematol"},{"key":"key20180107150104_b16-mco-0-0-947","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.3324\/haematol.2014.119032","article-title":"Refractory anemia with ring sideroblasts and marked thrombocytosis cases harbor mutations in SF3B1 or other spliceosome genes accompanied by JAK2V617F and ASXL1 mutations","volume":"100","author":"Jeromin","year":"2015","journal-title":"Haematologica"},{"key":"key20180107150104_b17-mco-0-0-947","first-page":"29","article-title":"Experience of the Polycythemia Vera study group with essential thrombocythemia: A final report on diagnostic criteria, survival, and leukemic transition by treatment","volume":"34","author":"Murphy","year":"1997","journal-title":"Semin Hematol"},{"key":"key20180107150104_b18-mco-0-0-947","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2353\/jmoldx.2006.060007","article-title":"JAK2 V617F in myeloid disorders: Molecular diagnostic techniques and their clinical utility: A paper from the 2005 William Beaumont Hospital Symposium on Molecular Pathology","volume":"8","author":"Steensma","year":"2006","journal-title":"J Mol Diagn"},{"key":"key20180107150104_b19-mco-0-0-947","first-page":"85","article-title":"Myelodysplastic\/myeloproliferative neoplasm, unclassifiable","author":"Vardiman","year":"2008","journal-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues"},{"key":"key20180107150104_b20-mco-0-0-947","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/leu.2008.119","article-title":"The myelodysplastic\/myeloproliferative neoplasms: Myeloproliferative diseases with dysplastic features","volume":"22","author":"Orazi","year":"2008","journal-title":"Leukemia"},{"key":"key20180107150104_b21-mco-0-0-947","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1182\/blood-2006-02-005751","article-title":"Refractory anemia with ringed sideroblasts associated with marked thrombocytosis (RARS-T), another myeloproliferative condition characterized by JAK2 V617F mutation","volume":"108","author":"Szpurka","year":"2006","journal-title":"Blood"},{"key":"key20180107150104_b22-mco-0-0-947","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.beha.2013.09.005","article-title":"Refractory anemia with ring sideroblasts","volume":"26","author":"Malcovati","year":"2013","journal-title":"Best Pract Res Clin Haematol"},{"key":"key20180107150104_b23-mco-0-0-947","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/ajh.24038","article-title":"Refractory anemia with ring sideroblasts and RARS with thrombocytosis","volume":"90","author":"Patnaik","year":"2015","journal-title":"Am J Hematol"},{"key":"key20180107150104_b24-mco-0-0-947","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/oem.51.8.530","article-title":"Cancer incidence and mortality among Swedish leather tanners","volume":"51","author":"Mikoczy","year":"1994","journal-title":"Occup Environ Med"},{"key":"key20180107150104_b25-mco-0-0-947","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1136\/oem.53.7.463","article-title":"Cancer incidence and specific occupational exposures in the Swedish leather tanning industry: A cohort based case-control study","volume":"53","author":"Mikoczy","year":"1996","journal-title":"Occup Environ Med"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mco.2016.947\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T05:45:21Z","timestamp":1600839921000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mco.2016.947"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,1]]},"references-count":25,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,7,1]]},"published-print":{"date-parts":[[2016,9]]}},"alternative-id":["10.3892\/mco.2016.947"],"URL":"https:\/\/doi.org\/10.3892\/mco.2016.947","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,1]]}}}